
Next Generation Central Nervous System AI Medical Imaging Solutions
Pursuing Faster, More Accurate Brain Disease Diagnosis & Helping To Reduce Drug Development Time

Parkinson's Disease
The World's First MRI Based Parkinson's Disease AI Solutions
Heuron IPD
.png)
Identification of the presence or absence of nigrostriatal degeneration
Heuron NI
.png)
Quantification and volumetric analysis of the nigrosome 1 region
Detection Of Dopaminergic Neuron: A Paradigm Shift To MRI

Early Diagnosis Of Parkinson's Disease

Alzheimer's Disease
Fully Automated Software With Greater Segmentation, Less Image Artifacts And Faster Processing Time
Heuron Brain PET
.png)
Automatic co-registration of MRI and PET
105 brain regions segmentation
Multiple PET tracers analysis, including Amyloid, Tau, FDG and FP-CIT
Standardize uptake value ratio calculation and the volume
Partial volume correction option
Heuron AD
.png)
Automatic labeling, visualization and volumetric quantification of 99 brain regions using MRI
Calculation of cerebral cortical atrophy, including volumes and thickness
Colour-coded segmentation overlays
Heuron AD Morphometric Reports
Longitudinal analysis: Monitoring brain volume changes over time to track the progression of the patient with neurodegenerative disease, like alzheimer's disease. Results compared to normative reference data adjusted for age and gender
Stroke
Identifies The Most Urgent Cases Within 3 Minutes
Heuron ICH
.png)
Non - Contrast CT Based AI Solutions For The Early Screening Of Hemorrhagic Stroke
Identification of intracerebral hemorrhage
Heuron ELVO
.png)
Non - Contrast CT Based AI Solutions For The Early Screening Of Ischemic Stroke
Identification Of Large Vessel Occlusion
Heuron ASPECTS
.png)
Calculation of Alberta Stroke Program Early CT Score (ASPECT) to measure the degree of damage caused by ischemic stroke
Enhances Diagnostic Workflow Of Both Primary Stroke Centres And Thrombectomy Capable Hospitals (link phone app)
Potentially Cut Clinical Decision-Making Process By 1 Hour

Brain Metastasis
MRI-Based AI Solution To Quantify And Locate Brain Metastases
Heuron METS
.png)
Detection Of Suspected Multiple Lesions In The Brain And Provides Total And Each Volume Of Lesions Detected Along With Talairach Coordinates (Atlas)
Heuron METS Analysis Report
.png)
.png)
Heuron Co., Ltd. is a medical AI software company established in 2017 that provides diagnosis aid solutions for central nervous system disorders, including Parkinson's disease, Alzheimer's disease, stroke, and brain metastasis, based on the AI model by implementing clinical specialists' diagnostic insights. Heuron's research & development is led by specialists under the direction of Founder & Chairman Donghoon Shin (MD, Ph.D.).
​
Heuron is on a mission to transform current complex diagnostic challenges into simple solutions with innovative technology.
​

Helica Instruments Ltd
102 Kingsknowe Road North
Longstone
Edinburgh EH142DG
Tel : +44 0 131 443 4753

Helica Asia Pacific Pte Ltd